Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Update on Offer for Subscription

22 Jun 2021 17:22

RNS Number : 7588C
Amati AIM VCT PLC
22 June 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

AMATI AIM VCT PLC

LEI: 213800HAEDBBK9RWCD25

22 June 2021

Update on Offer for Subscription

Following the announcement made on 12 April 2021, the Board of Amati AIM VCT PLC (the "Company") has discussed the size and structure of the proposed offer for subscription (the "Offer") with the Company's investment manager. Having considered the deployment of funds over the last six months and the current pipeline of investment opportunities, the Company is seeking to raise £30 million over a 12 month period from the date of publication of the prospectus related to the Offer. Initially, subscriptions will be accepted for the 2021/2022 tax year only.

The Directors will also have discretion to utilise an over-allotment facility of up to £30 million, either in whole or in part. This facility will only be utilised if sufficient Qualifying Investments have been made from the initial proceeds of the Offer and the investment manager has identified further investment opportunities. In this event, the Company may also accept applications in respect of the 2022/2023 tax year.

Subject to certain conditions, the Board intends to open the Offer to existing shareholders for a limited period prior to opening the Offer to new investors.

The prospectus, which will contain the full details and terms and conditions of the Offer, will be available from www.amatiglobal.com as soon as the Offer is launched, which is expected to be at the end of July 2021. A further announcement will be made when the prospectus is available.

Further information

For further information please contact Samantha Dalby on 0131 503 9115 or email: info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAKKAAFXFEFA
Date   Source Headline
27th Nov 201711:30 amRNSDirector/PDMR Shareholding
27th Nov 201710:50 amRNSIssue of Equity
24th Nov 20172:28 pmRNSNet Asset Value(s)
23rd Nov 20173:25 pmRNSTransaction in Own Shares
21st Nov 201711:48 amRNSTransaction in Own Shares
21st Nov 20179:13 amRNSDirector/PDMR Shareholding
21st Nov 20178:37 amRNSIssue of Equity
17th Nov 20174:28 pmRNSNet Asset Value(s)
15th Nov 20173:35 pmRNSTransaction in Own Shares
13th Nov 20173:06 pmRNSNet Asset Value(s)
8th Nov 20172:48 pmRNSTransaction in Own Shares
8th Nov 20171:09 pmRNSTransaction in Own Shares - replacement
3rd Nov 201711:56 amRNSTransaction in Own Shares
2nd Nov 20175:13 pmRNSNet Asset Value(s)
1st Nov 20178:42 amRNSTotal Voting Rights
30th Oct 20172:16 pmRNSNet Asset Value(s)
30th Oct 201712:21 pmRNSTransaction in Own Shares
27th Oct 20174:54 pmRNSIssue of a Prospectus and Offers
20th Oct 20175:00 pmRNSNet Asset Value(s)
16th Oct 20175:28 pmRNSNet Asset Value(s)
13th Oct 20171:15 pmRNSTransaction in Own Shares
9th Oct 20174:10 pmRNSNet Asset Value(s)
5th Oct 20171:22 pmRNSTransaction in Own Shares
4th Oct 20177:49 amRNSDividend Declaration
3rd Oct 20171:28 pmRNSNet Asset Value(s)
2nd Oct 20178:28 amRNSTotal Voting Rights
29th Sep 20171:38 pmRNSTransaction in Own Shares
28th Sep 20175:05 pmRNSHalf-year Report
25th Sep 201712:27 pmRNSNet Asset Value(s)
22nd Sep 20172:00 pmRNSTransaction in Own Shares
18th Sep 201711:32 amRNSNet Asset Value(s)
15th Sep 20175:02 pmRNSTransaction in Own Shares
13th Sep 201711:22 amRNSTransaction in Own Shares
11th Sep 20174:05 pmRNSNet Asset Value(s)
11th Sep 201712:33 pmRNSTransaction in Own Shares
5th Sep 20174:36 pmRNSHolding(s) in Company
5th Sep 201710:18 amRNSNet Asset Value(s)
1st Sep 20179:30 amRNSTotal Voting Rights
30th Aug 201711:04 amRNSNet Asset Value(s)
25th Aug 20178:38 amRNSCompliance with MAR
23rd Aug 20174:59 pmRNSTransaction in Own Shares
21st Aug 20172:52 pmRNSNet Asset Value(s)
18th Aug 20179:19 amRNSTransaction in Own Shares
15th Aug 20178:07 amRNSNet Asset Value(s)
7th Aug 20175:14 pmRNSNet Asset Value(s)
2nd Aug 20171:21 pmRNSNet Asset Value(s)
1st Aug 20179:37 amRNSTotal Voting Rights
28th Jul 20172:36 pmRNSTransaction in Own Shares
26th Jul 20173:32 pmRNSTransaction in Own Shares
24th Jul 20178:51 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.